Understanding how NCK1 influences blood cell production in certain blood disorders
The role of NCK1 in CSF3R-driven myeloproliferative neoplasms
This study is looking at how a protein called NCK1 works with a receptor that helps make white blood cells, and it aims to find new ways to treat people with blood disorders that cause too many of these cells to be produced.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11000787 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called NCK1 in the signaling pathways activated by the Colony Stimulating Factor 3 Receptor (CSF3R), which is crucial for the production of neutrophils, a type of white blood cell. The study focuses on myeloproliferative neoplasms (MPNs), where mutations in CSF3R lead to excessive neutrophil production. By identifying how NCK1 interacts with CSF3R and influences the MAPK signaling pathway, the research aims to uncover new therapeutic targets that could improve treatment options for patients with these blood disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with myeloproliferative neoplasms, particularly those with mutations in the CSF3R gene.
Not a fit: Patients with blood disorders not related to CSF3R mutations or those with other types of blood cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better control blood cell production in patients with myeloproliferative neoplasms.
How similar studies have performed: Other research has shown promising results in targeting similar signaling pathways in blood disorders, suggesting that this approach may also yield beneficial outcomes.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Maniaci, Breanna Nicole — Oregon Health & Science University
- Study coordinator: Maniaci, Breanna Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.